Fostamatinib import price in 2025

Fostamatinib (Fostamatinib) is a drug used to treat chronic immune thrombocytopenia (ITP), a condition characterized by an abnormally low number of platelets in the blood that may cause unusual bruising or bleeding. Fotantinib is a kinase inhibitor that exerts its therapeutic effects by reducing platelet destruction.

The drug is available as an oral tablet and is generally recommended to be taken twice daily without being affected by food. To ensure efficacy, patients should try to take fotantinib at the same time every day and strictly follow the doctor's prescription. If you have any questions about the medication, you should consult your doctor or pharmacist in time and do not adjust the dosage on your own.

During treatment, patients may experience certain side effects, so doctors may adjust the treatment plan based on the patient's response, including reducing the dose, temporarily stopping the drug, or discontinuing treatment entirely. If the platelet count does not reach the expected level after 12 weeks of treatment, the doctor may also consider discontinuing treatment. Therefore, it is crucial to maintain good communication with the doctor so that necessary adjustments and management can be made based on the patient's actual condition to maximize treatment effectiveness and ensure safety.

Currently, the common specifications of fotantinib include100mg 60 tablets and 150mg 60 tablets. However, the original research version of fotantinib has not yet been launched in China, so the specific price and medical insurance policy are still unknown. In overseas markets, the German original version is usually priced between 20,000 to 40,000 yuan (the specific price will be affected by exchange rate fluctuations), which is relatively expensive. In addition, there are currently no generic versions of fotantinib in overseas markets. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.

Reference materials:https://medlineplus.gov/druginfo/meds/a618025.html